Summary for 9Z03
| Entry DOI | 10.2210/pdb9z03/pdb |
| EMDB information | 73688 |
| Descriptor | NACHT, LRR and PYD domains-containing protein 3, ADENOSINE-5'-DIPHOSPHATE, (4S,5S)-1-[(2E)-but-2-enoyl]-7-(3-chloro-5-fluorophenyl)-4-phenyl-1,7-diazaspiro[4.4]nonan-6-one, ... (4 entities in total) |
| Functional Keywords | inflammasome, nlrp3, allosteric, immune system |
| Biological source | Homo sapiens (human) |
| Total number of polymer chains | 1 |
| Total formula weight | 103554.90 |
| Authors | |
| Primary citation | Rogness, D.C.,Sievert, E.P.,Vartabedian, V.F.,Bernard, S.M.,Aitchison, E.,Tao, W.,Lindvall, M.,Qian, J.,Eissler, C.L.,Nordin, B.E.,Horning, B.D.,Kingston, C.,Lamb, K.N.,Bell, J.C.,Lu, B.,Pollock, J.,Shi, J.,Khattri, R.,Weinstein, D.S.,Patricelli, M.P.,Cook, B.N.,Simon, G.M. Chemoproteomic discovery of a brain-penetrant, covalent NLRP3 inhibitor that binds a novel allosteric pocket. Br.J.Pharmacol., 2026 Cited by PubMed Abstract: The NLRP3 inflammasome is an attractive therapeutic target for multiple inflammatory conditions. Although inhibitors have been developed, their chemical diversity is limited, and their properties are not ideal for brain penetrance, which is desirable for treating neuroinflammatory disorders. PubMed: 42569816DOI: 10.1111/bph.70626 PDB entries with the same primary citation |
| Experimental method | ELECTRON MICROSCOPY (3.03 Å) |
Structure validation
Download full validation report






